Browsing by Author "Joseph, Jensa Mariam"
Now showing items 1-2 of 2
-
Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression
Abdulrahman, Nabeel; Ibrahim, Meram; Joseph, Jensa Mariam; Elkoubatry, Hanan Mahmoud; Al-Shamasi, Al Anood; Rayan, Menatallah; Gadeau, Alain Pierre; Ahmed, Rashid; Eldassouki, Hussein; Hasan, Anwarul; Mraiche, Fatima... more authors ... less authors ( Springer , 2022 , Article)Diabetes mellitus (DM)-induced cardiac morbidities have been the leading cause of death among diabetic patients. Recently, sodium-glucose cotransporter-2 (SGLT-2) inhibitors including empagliflozin (EMPA), which have been ... -
Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells
Abdulrahman, Nabeel; Siveen, Kodappully Sivaraman; Joseph, Jensa Mariam; Osman, Aisha; Yalcin, Huseyin C.; Hasan, Anwarul; Uddin, Shahab; Mraiche, Fatima... more authors ... less authors ( Wiley , 2020 , Article)© 2020 Royal Pharmaceutical Society Aim: Cisplatin is a standard treatment approach against lung adenocarcinoma. Resistance to cisplatin and the toxic side effects of cisplatin continue to remain a challenge. Combining ...